Impacts of genetic analysis and patient advocacy for extremely rare diseases

Marshall L. Summar, MD, Chief of the Division of Genetics and Metabolism at Children’s National Medical Center in Washington, DC, talked to Medscape about the role of patients and families, advocacy groups, and patient registries in furthering our understanding of pathophysiology and finding innovative treatments for rare disease.

Summar: Patient registries are one of the most important things we can do in this field. With more than 7000 different diseases, we simply don’t know enough.

There’s an old saying: “Know what you know, and know what you don’t know.” With these rare diseases, we don’t even know what we don’t know. The way to find that out is to develop these longitudinal registries (also known as “natural history studies”).

Read the full, original interview: A Golden Age for Rare Diseases

Outbreak Daily Digest
Biotech Facts & Fallacies
Genetics Unzipped
Infographic: How dangerous COVID mutant strains develop

Infographic: How dangerous COVID mutant strains develop

Sometime in 2019, probably in China, SARS CoV-2 figured out a way to interact with a specific "spike" on the ...

Philip Njemanze: Leading African anti-GMO activist claims Gates Foundation destroying Nigeria

Nigerian anti-GMO activist, physician, and inventor pushes anti-gay and anti-GMO ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend